Trial Profile
Phase II study of ABC 294640 +/- antineoplastics in patients with advanced cancers.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2010
Price :
$35
*
At a glance
- Drugs Opaganib (Primary) ; Antineoplastics
- Indications Cancer
- Focus Therapeutic Use
- Sponsors Apogee Biotechnology Corporation
- 10 Nov 2010 New trial record